| Dr Shin Wakatsuki, MD | |
|
321 N Kuakini St Ste 306, Honolulu, HI 96817-2360 | |
| (808) 792-9888 | |
| Not Available |
| Full Name | Dr Shin Wakatsuki |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 321 N Kuakini St Ste 306, Honolulu, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770003246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD-23220 (Hawaii) | Primary |
| Entity Name | Pacific Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538472451 PECOS PAC ID: 1951596329 Enrollment ID: O20101110001400 |
News Archive
According to SDI, a leading healthcare market insight and analytics firm that consolidates electronic healthcare claims data, there have been over 477,000 seasonal flu vaccinations already administered through Aug. 29 — the fourth week of this year's flu season. That is an increase of 237% compared to the same four weeks during last season.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Mathematicians are now developing completely new statistical calculations on the world's fastest computers in order to be able to predict how epidemics of dangerous hospital bacteria spread.
The German Research Foundation (DFG) is establishing a new research unit at Johannes Gutenberg University Mainz (JGU). The interdisciplinary group will examine how new biomedical capabilities can lead to extreme experiences in human life.
A team of American infectious disease and critical care experts is alerting colleagues caring for Ebola patients that how they remove their personal protective gear can be just as crucial as wearing it to prevent exposure to the deadly virus.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shin Wakatsuki, MD 321 N Kuakini St Ste 306, Honolulu, HI 96817-2360 Ph: (808) 792-9888 | Dr Shin Wakatsuki, MD 321 N Kuakini St Ste 306, Honolulu, HI 96817-2360 Ph: (808) 792-9888 |
News Archive
According to SDI, a leading healthcare market insight and analytics firm that consolidates electronic healthcare claims data, there have been over 477,000 seasonal flu vaccinations already administered through Aug. 29 — the fourth week of this year's flu season. That is an increase of 237% compared to the same four weeks during last season.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Mathematicians are now developing completely new statistical calculations on the world's fastest computers in order to be able to predict how epidemics of dangerous hospital bacteria spread.
The German Research Foundation (DFG) is establishing a new research unit at Johannes Gutenberg University Mainz (JGU). The interdisciplinary group will examine how new biomedical capabilities can lead to extreme experiences in human life.
A team of American infectious disease and critical care experts is alerting colleagues caring for Ebola patients that how they remove their personal protective gear can be just as crucial as wearing it to prevent exposure to the deadly virus.
› Verified 1 days ago
Dr. Hee Jung Park, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 321 N Kuakini St Ste 306, Honolulu, HI 96817 Phone: 808-792-9888 | |
Vien That Ton, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1575 S Beretania St #201-202, Honolulu, HI 96826 Phone: 808-946-1712 Fax: 808-946-1728 | |
Rony Newton Rathod, PA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1401 S Beretania St Ste 400, Honolulu, HI 96814 Phone: 808-206-5301 | |
Sontaya L Fujikake, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1575 South Beretania Street, # 201 To 202, Honolulu, HI 96826 Phone: 808-946-1712 Fax: 808-946-1728 | |
Jun Zhuo Luo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2914 Booth Rd Apt 12, Honolulu, HI 96813 Phone: 801-598-3679 | |
Lance M. Blaisdell, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Ligaya Stice, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-536-0314 |